Total buying$00 buys
SKYE
Skye Bioscience, Inc.
NasdaqHealthcarePharmaceutical Preparations
Insider activity for last month from 09/19 to 10/19.
How these metrics are calculated
Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total selling$479k8 sells
Net open-market−$479kBuying minus selling
Active insiders9Distinct reporting owners
Insider activity report
Calendar-month buckets within the selected date range
Latest filing: Sep 24, 2026
Open-market transaction mix · 8 transactions in the selected period
Code A includes awards, grants and other acquisitions; these are not open-market buys. A rolling period can include partial calendar months.
View exact monthly counts and disclosed values
| Month | Buys | Sells | Awards (A) | Buy value | Sell value | Net P/S value |
|---|---|---|---|---|---|---|
| Sep 2026 | 0 | 8 | 0 | $0 | $479k | -$479k |
| Oct 2026 | 0 | 0 | 0 | $0 | $0 | $0 |
Distinct insiders active
Reporting-owner CIKs by month · peak Sep 2026 (9)Sep 2026Oct 2026
Largest insider activity
By absolute net disclosed value · current transaction page- SJ-$239.6k
- 5L-$239.6k
SKYE transaction history
Newest filings · 20 transactions per pageLatest insider transactions
Form 4 filings from last month.| Company | Insider | Activity | Disclosed value | Filed (ET) |
|---|---|---|---|---|
SKYESkye Bioscience, Inc. | Schwab Andrew J.DIR | S · saleSEC filing ↗ | -$7.29kView disclosure → | |
SKYESkye Bioscience, Inc. | Schwab Andrew J.DIR | S · saleSEC filing ↗ | -$184kView disclosure → | |
SKYESkye Bioscience, Inc. | Schwab Andrew J.DIR | S · saleSEC filing ↗ | -$1.79kView disclosure → | |
SKYESkye Bioscience, Inc. | Schwab Andrew J.DIR | S · saleSEC filing ↗ | -$45.5kView disclosure → | |
SKYESkye Bioscience, Inc. | 5Am Partners VII, LLC10% | S · saleSEC filing ↗ | -$7.29kView disclosure → | |
SKYESkye Bioscience, Inc. | 5Am Partners VII, LLC10% | S · saleSEC filing ↗ | -$184kView disclosure → | |
SKYESkye Bioscience, Inc. | 5Am Partners VII, LLC10% | S · saleSEC filing ↗ | -$1.79kView disclosure → | |
SKYESkye Bioscience, Inc. | 5Am Partners VII, LLC10% | S · saleSEC filing ↗ | -$45.5kView disclosure → |
Filing-only signals
Deterministic matches in the selected period
Filing detail checks
Secondary metrics for the selected periodTransaction codes
By Form 4 transaction code in selected period8transactionstxns
- S · Open-market sells · dominant8 · 100%
Activity by reported role
A joint filing can contribute to multiple roles10% owner4
Director4
Reported Holdings After
Separated by insider, security, and ownership type
Rocklage Scott MCommon Stock · Indirect · By 5AM Ventures II, L.P.
0Sep 23, 2026
Rocklage Scott MCommon Stock · Indirect · By 5AM Co-Investors II, L.P.
0Sep 23, 2026
Diekman John DCommon Stock · Indirect · By 5AM Ventures II, L.P.
0Sep 23, 2026
Diekman John DCommon Stock · Indirect · By 5AM Co-Investors II, L.P.
0Sep 23, 2026
5Am Ventures II LPCommon Stock · Indirect · By 5AM Ventures II, L.P.
0Sep 23, 2026
5Am Ventures II LPCommon Stock · Indirect · By 5AM Co-Investors II, L.P.
0Sep 23, 2026
5Am Co-Investors II LPCommon Stock · Indirect · By 5AM Ventures II, L.P.
0Sep 23, 2026
5Am Co-Investors II LPCommon Stock · Indirect · By 5AM Co-Investors II, L.P.
0Sep 23, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Current transaction page only · each cell is a filing date · buys green, sells redSep 19 → Oct 19
LessMore
Skye Bioscience, Inc. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at Skye Bioscience, Inc.?
Schwab Andrew J., 5AM CO-INVESTORS II LP, 5AM Partners II, LLC, 5AM Partners VII, LLC, 5AM Ventures II LP, 5AM Ventures VII, L.P., DIEKMAN JOHN D, PARMAR KUSH, ROCKLAGE SCOTT M.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
Schwab Andrew J. reported a sale on Sep 23, 2026 valued at $7.29k. Read the SEC filing.
What is the recent purchase and sale balance?
Net open-market selling in the selected period was $479,110.38. Sales can occur for many non-investment reasons.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.